{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:02:46Z","timestamp":1795194166339,"version":"4.10.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05743-7","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:29:14Z","timestamp":1763137754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early mortality in patients with acute promyelocytic leukemia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"29","author":[{"given":"Dara","family":"Chean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiane","family":"Fodil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"2","key":"5743_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","volume":"72","author":"ME Huang","year":"1988","unstructured":"Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72(2):567\u201372.","journal-title":"Blood"},{"issue":"20","key":"5743_CR2","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1056\/NEJM199105163242002","volume":"324","author":"RP Warrell","year":"1991","unstructured":"Warrell RP, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN. Differentiation therapy of acute promyelocytic leukemia with tretinoin (All-trans-retinoic acid). N Engl J Med. 1991;324(20):1385\u201393.","journal-title":"N Engl J Med"},{"issue":"15","key":"5743_CR3","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJM199710093371501","volume":"337","author":"MS Tallman","year":"1997","unstructured":"Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337(15):1021\u20138.","journal-title":"N Engl J Med"},{"issue":"19","key":"5743_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","volume":"339","author":"SL Soignet","year":"1998","unstructured":"Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 1998;339(19):1341\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"5743_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1300874","volume":"369","author":"F Lo-Coco","year":"2013","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369(2):111\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"5743_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1200\/JCO.2016.67.1982","volume":"35","author":"U Platzbecker","year":"2017","unstructured":"Platzbecker U, Avvisati G, Cicconi L, Thiede C, Paoloni F, Vignetti M, et al. Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the randomized Italian-German APL0406 trial. J Clin Oncol. 2017;35(6):605\u201312.","journal-title":"J Clin Oncol"},{"issue":"25","key":"5743_CR7","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1182\/blood-2010-06-288613","volume":"116","author":"MS Tallman","year":"2010","unstructured":"Tallman MS, Kim HT, Montesinos P, Appelbaum FR, de la Serna J, Bennett JM, et al. Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American intergroup and the PETHEMA group. Blood. 2010;116(25):5650\u20139.","journal-title":"Blood"},{"issue":"1","key":"5743_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1182\/hematology.2023000477","volume":"2023","author":"O Odetola","year":"2023","unstructured":"Odetola O, Tallman MS. How to avoid early mortality in acute promyelocytic leukemia. Hematology. 2023;2023(1):248\u201353.","journal-title":"Hematology"},{"issue":"2","key":"5743_CR9","first-page":"169","volume":"18","author":"GS Guru Murthy","year":"2020","unstructured":"Guru Murthy GS, Szabo A, Michaelis L, Carlson KS, Runaas L, Abedin S, et al. Improving outcomes of acute promyelocytic leukemia in the current era: analysis of the SEER database. J Natl Compr Canc Netw. 2020;18(2):169\u201375.","journal-title":"J Natl Compr Canc Netw"},{"key":"5743_CR10","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"5743_CR11","unstructured":"Wells G, Shea B, O\u2019Connell D, Robertson J, Peterson J, Losos M et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta- Analysis."},{"issue":"1","key":"5743_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13.","journal-title":"BMC Med Res Methodol"},{"key":"5743_CR13","doi-asserted-by":"crossref","unstructured":"Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. J Stat Soft [Internet]. 2010 [cited 2023 Nov 7];36(3). Available from: http:\/\/www.jstatsoft.org\/v36\/i03\/","DOI":"10.18637\/jss.v036.i03"},{"issue":"2","key":"5743_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1182\/bloodadvances.2021005642","volume":"6","author":"JP Bewersdorf","year":"2022","unstructured":"Bewersdorf JP, Prozora S, Podoltsev NA, Shallis RM, Huntington SF, Neparidze N, et al. Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the united States. Blood Adv. 2022;6(2):376\u201385.","journal-title":"Blood Adv"},{"issue":"7","key":"5743_CR15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00134-019-05653-7","volume":"45","author":"M Darmon","year":"2019","unstructured":"Darmon M, Bourmaud A, Georges Q, Soares M, Jeon K, Oeyen S, et al. Changes in critically ill cancer patients\u2019 short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med. 2019;45(7):977\u201387.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5743_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01409-9","volume":"15","author":"D Chean","year":"2025","unstructured":"Chean D, Luque-Paz D, Poole D, Fodil S, Lenglin\u00e9 E, Dupont T, et al. Critically ill adult patients with acute leukemia: a systematic review and meta-analysis. Ann Intensive Care. 2025;15(1):9.","journal-title":"Ann Intensive Care"},{"issue":"5","key":"5743_CR17","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2589-7500(24)00044-X","volume":"6","author":"V Alcazer","year":"2024","unstructured":"Alcazer V, Le Meur G, Roccon M, Barriere S, Le Calvez B, Badaoui B, et al. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France. Lancet Digit Health. 2024;6(5):e323\u201333.","journal-title":"Lancet Digit Health"},{"issue":"4","key":"5743_CR18","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1200\/OP.20.00395","volume":"17","author":"AP Jillella","year":"2021","unstructured":"Jillella AP, Arellano ML, Gaddh M, Langston AA, Heffner LT, Winton EF, et al. Comanagement strategy between academic institutions and community practices to reduce induction mortality in acute promyelocytic leukemia. JCO Oncol Pract. 2021;17(4):e497\u2013505.","journal-title":"JCO Oncol Pract"},{"issue":"11","key":"5743_CR19","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.6004\/jnccn.2021.7013","volume":"19","author":"MJ Geer","year":"2021","unstructured":"Geer MJ, Foucar CE, Devata S, Benitez L, Perissinotti AJ, Marini BL, et al. Clinical availability of ATRA for patients with suspected acute promyelocytic leukemia: why guidelines may not be followed. J Natl Compr Canc Netw. 2021;19(11):1272\u20135.","journal-title":"J Natl Compr Canc Netw"},{"issue":"15","key":"5743_CR20","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","volume":"133","author":"MA Sanz","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS, Estey EH, L\u00f6wenberg B, Naoe T, et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019;133(15):1630\u201343.","journal-title":"Blood"},{"issue":"2","key":"5743_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/bjh.16151","volume":"187","author":"M Stahl","year":"2019","unstructured":"Stahl M, Tallman MS. Differentiation syndrome in acute promyelocytic leukaemia. Br J Haematol. 2019;187(2):157\u201362.","journal-title":"Br J Haematol"},{"issue":"6","key":"5743_CR22","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcyt.2023.01.007","volume":"25","author":"H Lee","year":"2023","unstructured":"Lee H, Yoon JH, Cho BS, Kim HJ, Jekarl DW, Kim Y. Clinical outcomes of therapeutic leukapheresis in acute promyelocytic leukemia: a single-center retrospective cohort study. Cytotherapy. 2023;25(6):659\u201369.","journal-title":"Cytotherapy"},{"issue":"5","key":"5743_CR23","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1111\/bjh.19759","volume":"205","author":"L Cicconi","year":"2024","unstructured":"Cicconi L, Bisegna M, Gurnari C, Fanciullo D, Piciocchi A, Marsili G, et al. Leucocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications. Br J Haematol. 2024;205(5):1727\u201333.","journal-title":"Br J Haematol"},{"issue":"7","key":"5743_CR24","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3109\/10428194.2011.649752","volume":"53","author":"E Lenglin\u00e9","year":"2012","unstructured":"Lenglin\u00e9 E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N, et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma. 2012;53(7):1352\u20139.","journal-title":"Leuk Lymphoma"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05743-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05743-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05743-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T19:03:23Z","timestamp":1763406203000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05743-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5743"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05743-7","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"490"}}